These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
878 related items for PubMed ID: 25151964
21. Anti-angiogenic activity of thienopyridine derivative LCB03-0110 by targeting VEGFR-2 and JAK/STAT3 Signalling. Kim BH, Lee Y, Yoo H, Cui M, Lee S, Kim SY, Cho JU, Lee H, Yang BS, Kwon YG, Choi S, Kim TY. Exp Dermatol; 2015 Jul; 24(7):503-9. PubMed ID: 25808463 [Abstract] [Full Text] [Related]
22. Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression. Wang Y, Mou Y, Zhang H, Wang X, Li R, Cheng Z, Liu X. Int J Med Sci; 2017 Jul; 14(13):1402-1409. PubMed ID: 29200954 [Abstract] [Full Text] [Related]
23. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma. Ashizawa T, Miyata H, Iizuka A, Komiyama M, Oshita C, Kume A, Nogami M, Yagoto M, Ito I, Oishi T, Watanabe R, Mitsuya K, Matsuno K, Furuya T, Okawara T, Otsuka M, Ogo N, Asai A, Nakasu Y, Yamaguchi K, Akiyama Y. Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755 [Abstract] [Full Text] [Related]
24. Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma. Tornin J, Martinez-Cruzado L, Santos L, Rodriguez A, Núñez LE, Oro P, Hermosilla MA, Allonca E, Fernández-García MT, Astudillo A, Suarez C, Morís F, Rodriguez R. Oncotarget; 2016 May 24; 7(21):30935-50. PubMed ID: 27105533 [Abstract] [Full Text] [Related]
25. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling. Su M, Huang J, Li J, Qin X, Tang X, Jin F, Chen S, Jiang C, Zou Z, Peng K, Nuruzzaman M, Zhang J, Luo J, Liu S, Luo Z. Oncotarget; 2016 Apr 05; 7(14):19018-30. PubMed ID: 26967559 [Abstract] [Full Text] [Related]
26. Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway. Choi HS, Kim JH, Kim SL, Deng HY, Lee D, Kim CS, Yun BS, Lee DS. Mol Carcinog; 2018 Nov 05; 57(11):1467-1479. PubMed ID: 29964299 [Abstract] [Full Text] [Related]
27. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling. Zhang E, Chen Z, Liu W, Lin L, Wu L, Guan J, Wang J, Kong C, Bi J, Zhang M. J Transl Med; 2024 Jan 02; 22(1):12. PubMed ID: 38166947 [Abstract] [Full Text] [Related]
28. circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression. Zhan W, Liao X, Wang Y, Li L, Li J, Chen Z, Tian T, He J. Carcinogenesis; 2019 Jun 10; 40(4):560-568. PubMed ID: 30403769 [Abstract] [Full Text] [Related]
29. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer. Han Z, Wang X, Ma L, Chen L, Xiao M, Huang L, Cao Y, Bai J, Ma D, Zhou J, Hong Z. Oncotarget; 2014 Sep 30; 5(18):8416-28. PubMed ID: 25261365 [Abstract] [Full Text] [Related]
30. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer. Li M, Li A, Zhou S, Lv H, Yang W. J Hematol Oncol; 2019 Feb 08; 12(1):14. PubMed ID: 30736840 [Abstract] [Full Text] [Related]
31. Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling. Lee SH, Lee KB, Lee JH, Kang S, Kim HG, Asahara T, Kwon SM. Stem Cells; 2015 May 08; 33(5):1490-500. PubMed ID: 25537795 [Abstract] [Full Text] [Related]
32. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling. Roy R, Dagher A, Butterfield C, Moses MA. Mol Cancer Res; 2017 Nov 08; 15(11):1608-1622. PubMed ID: 28765266 [Abstract] [Full Text] [Related]
33. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Wei ZW, Xia GK, Wu Y, Chen W, Xiang Z, Schwarz RE, Brekken RA, Awasthi N, He YL, Zhang CH. Cancer Lett; 2015 Apr 10; 359(2):335-43. PubMed ID: 25641338 [Abstract] [Full Text] [Related]
34. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth. Park J, Kim SY, Kim HJ, Kim KM, Choi EY, Kang MS. Oncotarget; 2016 May 10; 7(19):28670-83. PubMed ID: 27107424 [Abstract] [Full Text] [Related]
35. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D, Fu L, Sun H, Guo L, DuBois RN. Gastroenterology; 2015 Dec 10; 149(7):1884-1895.e4. PubMed ID: 26261008 [Abstract] [Full Text] [Related]
36. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells. Bora-Singhal N, Nguyen J, Schaal C, Perumal D, Singh S, Coppola D, Chellappan S. Stem Cells; 2015 Jun 10; 33(6):1705-18. PubMed ID: 25754111 [Abstract] [Full Text] [Related]
37. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y. Eur J Cancer; 2011 Oct 10; 47(15):2353-63. PubMed ID: 21680174 [Abstract] [Full Text] [Related]
38. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer. Gao W, Wen H, Liang L, Dong X, Du R, Zhou W, Zhang X, Zhang C, Xiang R, Li N. Theranostics; 2021 Oct 10; 11(6):2564-2580. PubMed ID: 33456560 [Abstract] [Full Text] [Related]
39. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, Ren ZG. J Hematol Oncol; 2015 Mar 11; 8():23. PubMed ID: 25879771 [Abstract] [Full Text] [Related]